Prelude Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Prelude Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,348	Closed	-$382K	–	2321
2019 Q1	$382K	Buy	7,348 +7,088	+2,726%	+$327K	0.02%	554
2018 Q4	$13K	Buy	260 +121	+87%	+$6.66K	﹤0.01%	1330
2018 Q3	$9K	Sell	139 -173	-55%	-$10.2K	﹤0.01%	1495
2018 Q2	$15K	Buy	+312	New	+$15.1K	﹤0.01%	1413
2018 Q1	–	Sell	-11,122	Closed	-$468K	–	1816
2017 Q4	$468K	Sell	11,122 -2,710	-20%	-$104K	0.04%	442
2017 Q3	$593K	Sell	13,832 -11,068	-44%	-$353K	0.05%	335
2017 Q2	$326K	Buy	24,900 +24,700	+12,350%	+$325K	0.03%	436
2017 Q1	$3K	Buy	+200	New	+$2.56K	﹤0.01%	1444

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Prelude Capital Management's MYOK Position: Q2 2019 in Review

Prelude Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2019, closing a stake of 7,348 shares — an estimated $382K sold.

Prelude Capital Management first reported a position in MYOK in Q1 2017 and held it in 8 quarters. The position peaked at $593K in Q3 2017. 155 funds tracked by Wall St. Rank hold MYOK as of Q2 2019.

Prelude Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Prelude Capital Management sold 7,348 MyoKardia, Inc. Common Stock shares in Q2 2019, an estimated $382K.
Prelude Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 8 quarters.
Prelude Capital Management's MyoKardia, Inc. Common Stock position peaked at $593K in Q3 2017.
155 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2019.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.